The University of Texas Health Science Center at San Antonio

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

260

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

11 drugs in development

Approved1

Phase 33

Phase 24

Phase 15

Preclinical3

By Therapeutic Area

top 4

Metabolic & Endocrine

533%

Oncology

427%

Cardiovascular

213%

Rare Disease

17%

R&D Momentum

82/100

Pipeline Velocity

55/100

Trial Completion Rate

79/100

Pipeline Concentration

24/100

Pipeline Freshness

72/100

Strategic Signals

↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Oct 31, 2026

Recruiting

Identification of Cell Type-Specific Insulin Responsive Quantitative Trait Loci (QTL) in Human Skeletal Muscle

Oct 23, 2026

Active, not recruiting

An Investigator Initiated Phase 2 Trial of the LSD1 Inhibitor IMG-7289 in Essential Thrombocythemia (CTMS# 19-0078)

Oct 22, 2026

Completed

Modulation of Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer

Earlier

Oct 16, 2026TrialMetformin for Preventing Frailty in High-risk Older Adults

Oct 16, 2026TrialASPIRED: Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department - A Randomized Clinical Trial.

Oct 14, 2026TrialA Pilot, Post-market, Non-interventional, Prospective, Observational Study of Standard of Care of the Commercially Available Borate-base Bioactive Glass Fiber Matrix (BBGFM) in Treatment of Outpatient Diabetic Foot Ulcer With Chronic Osteomyelitis.

Oct 8, 2026TrialMetabolic Mechanisms Induced by Enteral Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) Supplementation in Preterm Infants

Oct 7, 2026TrialThe Effects of Stellate Ganglion Block on Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for Posttraumatic Stress Disorder (PTSD)

1 more events

Oct 7, 2026Trial"SwallowFit," an Exercise Program and Randomized Clinical Trial Designed for US Service Members, Veterans, and Families Affected by Parkinson's Disease.

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(2 drugs)

—

Cardiovascular(2 drugs)

Metabolic & Endocrine(5 drugs)

—

Metabolic & Endocrine(5 drugs)

Oncology(4 drugs)

—

Oncology(4 drugs)

Rare Disease(1 drug)

—

Rare Disease(1 drug)

Unknown / Other(3 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)